HDAC regulation assays, compounds and therapeutic compositions

Details for Australian Patent Application No. 2006256783 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors De Schepper, Stefanie Helena; Arts, Janine; Vialard, Jorge Eduardo; Andries, Luc Joseph

Agent Shelston IP

Pub. Number AU-A-2006256783

PCT Pub. Number WO2006/131496

Priority 05110148.3 28.10.05 EP; 05104907.0 06.06.05 EP

Filing date 2 June 2006

Wipo publication date 14 December 2006

International Classifications

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

C12N 9/16 (2006.01) Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

C12Q 1/44 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving esterase

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/131496 Priority application(s): WO2006/131496

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006256791-Polypeptides having antimicrobial activity and polynucleotides encoding same

2006256778-Polymorphs of ethyl 3-[(2-{(4-(hexyloxycarbonylamino-imino methyl)phenylamino]methyl}-1-methyl-1 H-benzimidazole5-carbonyl)pyridin-2-ylamino)propionate